Latest Mergers And Acquisitions News

Jayride Group reports a sharp decline in bookings amid supplier payment challenges but eyes growth through API technology and cost cuts.

CZR Resources faces ongoing delays in FIRB approval for its $102 million Robe Mesa sale, prompting a strategic pause in exploration and an extension of its loan facility to sustain operations.

Triton Minerals has secured A$17 million from the sale of a 70% stake in its Mozambique graphite assets, while progressing environmental approvals and unveiling promising high-grade gold and copper results at its new Aucu project.

Cavalier Resources has successfully raised A$1.735 million through a rights issue, positioning the company to advance its Crawford Gold Project amid record gold prices and promising exploration results.

GWR Group Limited reports completion of phase two drilling at its Prospect Ridge Magnesium Project with assay results pending, while divesting its Hatches Creek interest to bolster focus and capital for growth.

Ragnar Metals advances its Swedish exploration with a significant spodumene pegmatite discovery at Orrvik and promising uranium assays at multiple new projects, while strengthening its strategic position through a key investment in Kaiser Reef.

Conico Ltd is exploring strategic options to enhance its Mt Thirsty cobalt-nickel project while navigating a significant arbitration ruling over drilling contracts in Greenland. The company also signals ongoing evaluation of new mineral exploration opportunities.

Wellnex Life Limited reported a 36% rise in Q2 FY25 cash receipts and record monthly sales, while advancing its dual listing on the London Stock Exchange and expanding into the UK market.

Eagle Mountain Mining has strengthened its Silver Mountain copper project prospects, initiated tailings repurposing at Wedgetail, and launched a capital raise to reduce debt, while relinquishing Oracle Ridge mineral rights due to unaligned landowner terms.

Pure Resources Limited has made significant strides in its Reedy Creek Garnet Project, expanding the resource and delivering promising metallurgical test results that highlight the project's commercial potential.

Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.

GBM Resources reports robust progress in its Queensland and South Australian gold projects, highlighted by a $12 million farm-in deal at Twin Hills and positive cash flow from White Dam. Exploration strategies and corporate restructuring set the stage for a pivotal 2025.